Dose

Data shows deaths in Australia are on the rise, however the timing in close proximity to the government’s mass mRNA vaccination campaign is suspicious, says one researcher.

VAERS data released Friday by the Centers for Disease Control and Prevention show 1,287,595 reports of adverse events from all age groups following COVID-19 vaccines, including 28,532 deaths and 235,041 serious injuries between Dec. 14, 2020, and May 27, 2022.

Young males are more likely to report heart damage following vaccination with an mRNA COVID-19 vaccine, and the damage is more likely to be reported after the second dose, according to research published May 25 in The BMJ.

Pfizer Inc and partner BioNTech have completed the filing with the U.S. drugs regulator seeking authorization for their COVID-19 vaccine in children under 5 years of age.

A New York City Department of Health and Mental Hygiene ad about drug use features a statement in quotes that declares, "Don't be ashamed you are using, be empowered that you are using safely" — the quote appears to be attributed to an individual named "Florence."

VAERS data released Friday by the Centers for Disease Control and Prevention show 1,277,980 reports of adverse events from all age groups following COVID-19 vaccines, including 28,312 deaths and 232,694 serious injuries between Dec. 14, 2020, and May 20, 2022

A final hearing began today in the investigation into the death of a 26-year-old man who died last year from “catastrophic” blood clots in his brain 13 days after receiving the AstraZeneca COVID-19 vaccine.

Publicly available data from VAERS clearly reveal that these shots are the most dangerous ‘vaccines’ ever created

A young boy died after getting Pfizer’s COVID-19 vaccine and evidence was found of the boy suffering from heart inflammation, Centers for Disease Control and Prevention (CDC) researchers revealed on May 19.

The U.S. Food and Drug Administration (FDA) today authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, without convening its vaccine advisory panel of independent experts to discuss Pfizer’s data on 5- to 11-year-olds — and based on a study subset of only 67 children, CNBC reported.